Flow (shear stress)-mediated remodeling of resistance arteries in diabetes

Vascular Pharmacology

Volumn 57, Issue 5-6, 2012, Pages 173-178

  Vessières, Emilie ^a   Freidja, Mohamed L ^a   Loufrani, Laurent ^a   Fassot, Céline ^a   Henrion, Daniel ^a  

^a UNIVERSITÉ D'ANGERS   (France)

Author keywords

Endothelium; Mechanotransduction; Remodeling; Resistance arteries; Shear stress

Indexed keywords

ADVANCED GLYCATION END PRODUCT; METALLOPROTEINASE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ARTERY RESISTANCE; BLOOD VESSEL TONE; DIABETES MELLITUS; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATION; MICROCIRCULATION; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SHEAR STRESS; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; DIABETES MELLITUS; ENDOTHELIUM, VASCULAR; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; NITRIC OXIDE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; REGIONAL BLOOD FLOW; SHEAR STRENGTH; VASCULAR RESISTANCE; VASODILATION;

EID: 84865627268     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2012.03.006     Document Type: Review

References (77)

1. Abdu T.A., Elhadd T., Pfeifer M., Clayton R.N. Endothelial dysfunction in endocrine disease. Trends Endocrinol. Metab. 2001, 12:257-265.
2. Aird W.C. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ. Res. 2007, 100:174-190.
3. Aird W.C. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ. Res. 2007, 100:158-173.
4. Bakker E.N., Buus C.L., Spaan J.A., Perree J., Ganga A., Rolf T.M., Sorop O., Bramsen L.H., Mulvany M.J., Vanbavel E. Small artery remodeling depends on tissue-type transglutaminase. Circ. Res. 2005, 96:119-126.
5. Bakker E.N., Pistea A., Spaan J.A., Rolf T., de Vries C.J., van Rooijen N., Candi E., VanBavel E. Flow-dependent remodeling of small arteries in mice deficient for tissue-type transglutaminase: possible compensation by macrophage-derived factor xiii. Circ. Res. 2006, 99:86-92.
6. Bakker E.N., Matlung H.L., Bonta P., de Vries C.J., van Rooijen N., Vanbavel E. Blood flow-dependent arterial remodelling is facilitated by inflammation but directed by vascular tone. Cardiovasc. Res. 2008, 78:341-348.
7. Belin de Chantemele E.J., Vessieres E., Guihot A.L., Toutain B., Maquignau M., Loufrani L., Henrion D. Type 2 diabetes severely impairs structural and functional adaptation of rat resistance arteries to chronic changes in blood flow. Cardiovasc. Res. 2009, 81:788-796.
8. Belin de Chantemele E.J., Vessieres E., Dumont O., Guihot A.L., Toutain B., Loufrani L., Henrion D. Reactive oxygen species are necessary for high flow (shear stress)-induced diameter enlargement of rat resistance arteries. Microcirculation 2009, 16:391-402.
9. Belin de Chantemele E.J., Vessieres E., Guihot A.L., Toutain B., Loufrani L., Henrion D. Cyclooxygenase-2 preserves flow-mediated remodelling in old obese Zucker rat mesenteric arteries. Cardiovasc. Res. 2010, 86:516-525.
10. Bevan J.A., Henrion D. Pharmacological implications of the flow-dependence of vascular smooth muscle tone. Annu. Rev. Pharmacol. Toxicol. 1994, 34:173-190.
11. Bevan J.A., Siegel G. Blood vessel wall matrix flow sensor: evidence and speculation. Blood Vessels 1991, 28:552-556.
12. Bohlen H.G. Protein kinase betaii in zucker obese rats compromises oxygen and flow-mediated regulation of nitric oxide formation. Am. J. Physiol. Heart Circ. Physiol. 2004, 286:H492-H497.
13. Bouvet C., de Chantemele E.B., Guihot A.L., Vessieres E., Bocquet A., Dumont O., Jardel A., Loufrani L., Moreau P., Henrion D. Flow-induced remodeling in resistance arteries from obese Zucker rats is associated with endothelial dysfunction. Hypertension 2007, 50:248-254.
14. Buschmann I., Schaper W. Arteriogenesis versus angiogenesis: Two mechanisms of vessel growth. News Physiol. Sci. 1999, 14:121-125.
15. Buus C.L., Pourageaud F., Fazzi G.E., Janssen G., Mulvany M.J., De Mey J.G. Smooth muscle cell changes during flow-related remodeling of rat mesenteric resistance arteries. Circ. Res. 2001, 89:180-186.
16. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 2000, 6:389-395.
17. Castier Y., Brandes R.P., Leseche G., Tedgui A., Lehoux S. P47phox-dependent nadph oxidase regulates flow-induced vascular remodeling. Circ. Res. 2005, 97:533-540.
18. Christen A.I., Armentano R.L., Miranda A., Graf S., Santana D.B., Zocalo Y., Baglivo H.P., Sanchez R.A. Arterial wall structure and dynamics in type 2 diabetes mellitus methodological aspects and pathophysiological findings. Curr. Diabetes Rev. 2010, 6:367-377.
19. Cipolla M.J., Gokina N.I., Osol G. Pressure-induced actin polymerization in vascular smooth muscle as a mechanism underlying myogenic behavior. FASEB J. 2002, 16:72-76.
20. Cousin M., Custaud M.A., Baron-Menguy C., Toutain B., Dumont O., Guihot A.L., Vessieres E., Subra J.F., Henrion D., Loufrani L. Role of angiotensin ii in the remodeling induced by a chronic increase in flow in rat mesenteric resistance arteries. Hypertension 2010, 55:109-115.
21. Djaberi R., Beishuizen E.D., Pereira A.M., Rabelink T.J., Smit J.W., Tamsma J.T., Huisman M.V., Jukema J.W. Non-invasive cardiac imaging techniques and vascular tools for the assessment of cardiovascular disease in type 2 diabetes mellitus. Diabetologia 2008, 51:1581-1593.
22. Dowell F.J., Henrion D., Duriez M., Michel J.B. Vascular reactivity in mesenteric resistance arteries following chronic nitric oxide synthase inhibition in Wistar rats. Br. J. Pharmacol. 1996, 117:341-346.
23. Dowell F.J., Henrion D., Benessiano J., Poitevin P., Levy B. Chronic infusion of low-dose angiotensin ii potentiates the adrenergic response in vivo. J. Hypertens. 1996, 14:177-182.
24. Dubroca C., Loyer X., Retailleau K., Loirand G., Pacaud P., Feron O., Balligand J.L., Levy B.I., Heymes C., Henrion D. Rhoa activation and interaction with caveolin-1 are critical for pressure-induced myogenic tone in rat mesenteric resistance arteries. Cardiovasc. Res. 2007, 73:190-197.
25. Dumont O., Loufrani L., Henrion D. Key role of the no-pathway and matrix metalloprotease-9 in high blood flow-induced remodeling of rat resistance arteries. Arterioscler. Thromb. Vasc. Biol. 2007, 27:317-324.
26. Dumont O., Pinaud F., Guihot A.L., Baufreton C., Loufrani L., Henrion D. Alteration in flow (shear stress)-induced remodelling in rat resistance arteries with aging: improvement by a treatment with hydralazine. Cardiovasc. Res. 2008, 77:600-608.
27. Enevoldsen L.H., Stallknecht B., Fluckey J.D., Galbo H. Effect of exercise training on in vivo insulin-stimulated glucose uptake in intra-abdominal adipose tissue in rats. Am. J. Physiol. Endocrinol. Metab. 2000, 278:E25-E34.
28. Feletou M., Vanhoutte P.M. Endothelial dysfunction: a multifaceted disorder (the Wiggers award lecture). Am. J. Physiol. Heart Circ. Physiol. 2006, 291:H985-H1002.
29. Freidja M.L., Vessieres E., Clere N., Desquiret V., Guihot A.L., Toutain B., Loufrani L., Jardel A., Procaccio V., Faure S., Henrion D. Heme oxygenase-1 induction restores high-blood-flow-dependent remodeling and endothelial function in mesenteric arteries of old rats. J. Hypertens. 2011, 29:102-112.
30. Freidja M.L., Toutain B., Caillon A., Desquiret V., Lambert D., Loufrani L., Procaccio V., Henrion D. Heme oxygenase 1 is differentially involved in blood flow-dependent arterial remodeling: role of inflammation, oxidative stress, and nitric oxide. Hypertension 2011, 58:225-231.
31. Freidja M.L., Tarhouni K., Toutain B., Fassot-Lucht C., Loufrani L., Henrion D. The age-breaker alt-711 restores high blood flow-dependent remodeling in mesenteric resistance arteries in a rat model of type 2 diabetes. Diabetes 2012, 2012 Mar 13. (Epub ahead of print) PMID: 22415880.
32. Gao L., Mann G.E. Vascular nad(p)h oxidase activation in diabetes: a double-edged sword in redox signalling. Cardiovasc. Res. 2009, 82:9-20.
33. Goldin A., Beckman J.A., Schmidt A.M., Creager M.A. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 2006, 114:597-605.
34. Gorny D., Loufrani L., Kubis N., Levy B.I., Henrion D. Chronic hydralazine improves flow (shear stress)-induced endothelium-dependent dilation in mouse mesenteric resistance arteries in vitro. Microvasc. Res. 2002, 64:127-134.
35. Henrion D. Pressure and flow-dependent tone in resistance arteries. Role of myogenic tone. Arch. Mal. Coeur Vaiss. 2005, 98:913-921.
36. Henrion D., Laher I., Laporte R., Bevan J.A. Further evidence from an elastic artery that angiotensin ii amplifies noradrenaline-induced contraction through activation of protein kinase c. Eur. J. Pharmacol. 1992, 224:13-20.
37. Henrion D., Laher I., Laporte R., Bevan J.A. Angiotensin ii amplifies arterial contractile response to norepinephrine without increasing ca++ influx: role of protein kinase c. J. Pharmacol. Exp. Ther. 1992, 261:835-840.
38. Henrion D., Benessiano J., Levy B.I. In vitro modulation of a resistance artery diameter by the tissue renin-angiotensin system of a large donor artery. Circ. Res. 1997, 80:189-195.
39. Hill M.A., Davis M.J., Meininger G.A., Potocnik S.J., Murphy T.V. Arteriolar myogenic signalling mechanisms: Implications for local vascular function. Clin. Hemorheol. Microcirc. 2006, 34:67-79.
40. Iglarz M., Matrougui K., Levy B.I., Henrion D. Chronic blockade of endothelin eta receptors improves flow dependent dilation in resistance arteries of hypertensive rats. Cardiovasc. Res. 1998, 39:657-664.
41. Koller A., Huang A., Sun D., Kaley G. Exercise training augments flow-dependent dilation in rat skeletal muscle arterioles. Role of endothelial nitric oxide and prostaglandins. Circ. Res. 1995, 76:544-550.
42. Korkmaz H., Onalan O. Evaluation of endothelial dysfunction: flow-mediated dilation. Endothelium 2008, 15:157-163.
43. Langille B.L. Arterial remodeling: relation to hemodynamics. Can. J. Physiol. Pharmacol. 1996, 74:834-841.
44. Lehoux S., Castier Y., Tedgui A. Molecular mechanisms of the vascular responses to haemodynamic forces. J. Intern. Med. 2006, 259:381-392.
45. Loufrani L., Li Z., Levy B.I., Paulin D., Henrion D. Excessive microvascular adaptation to changes in blood flow in mice lacking gene encoding for desmin. Arterioscler. Thromb. Vasc. Biol. 2002, 22:1579-1584.
46. Matlung H.L., Bakker E.N., VanBavel E. Shear stress, reactive oxygen species, and arterial structure and function. Antioxid. Redox Signal. 2009, 11:1699-1709.
47. Matrougui K., Loufrani L., Heymes C., Levy B.I., Henrion D. Activation of at(2) receptors by endogenous angiotensin ii is involved in flow-induced dilation in rat resistance arteries. Hypertension 1999, 34:659-665.
48. Matrougui K., Levy B.I., Henrion D. Tissue angiotensin ii and endothelin-1 modulate differently the response to flow in mesenteric resistance arteries of normotensive and spontaneously hypertensive rats. Br. J. Pharmacol. 2000, 130:521-526.
49. Miller S.J., Coppinger B.J., Zhou X., Unthank J.L. Antioxidants reverse age-related collateral growth impairment. J. Vasc. Res. 2010, 47:108-114.
50. Mulvany M.J. Small artery remodeling in hypertension. Curr. Hypertens. Rep. 2002, 4:49-55.
51. Nakae I., Fujita M., Miwa K., Hasegawa K., Kihara Y., Nohara R., Miyamoto S., Ueda K., Tamaki S., Sasayama S. Age-dependent impairment of coronary collateral development in humans. Heart Vessels 2000, 15:176-180.
52. Pourageaud F., De Mey J.G. Structural properties of rat mesenteric small arteries after 4-wk exposure to elevated or reduced blood flow. Am. J. Physiol. 1997, 273:H1699-H1706.
53. Pourageaud F., De Mey J.G. Vasomotor responses in chronically hyperperfused and hypoperfused rat mesenteric arteries. Am. J. Physiol. 1998, 274:H1301-H1307.
54. Prewitt R.L., Rice D.C., Dobrian A.D. Adaptation of resistance arteries to increases in pressure. Microcirculation 2002, 9:295-304.
55. Retailleau K., Belin de Chantemele E.J., Chanoine S., Guihot A.L., Vessieres E., Toutain B., Faure S., Bagi Z., Loufrani L., Henrion D. Reactive oxygen species and cyclooxygenase 2-derived thromboxane a2 reduce angiotensin ii type 2 receptor vasorelaxation in diabetic rat resistance arteries. Hypertension 2010, 55:339-344.
56. Rizzoni D., Rosei E.A. Small artery remodeling in diabetes mellitus. Nutr. Metab. Cardiovasc. Dis. 2009, 19:587-592.
57. Rocic P., Kolz C., Reed R., Potter B., Chilian W.M. Optimal reactive oxygen species concentration and p38 map kinase are required for coronary collateral growth. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H2729-H2736.
58. Romanko O.P., Stepp D.W. Reduced constrictor reactivity balances impaired vasodilation in the mesenteric circulation of the obese Zucker rat. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H2097-H2102.
59. Rosei E.A., Rizzoni D. Small artery remodelling in diabetes. J. Cell. Mol. Med. 2010, 14:1030-1036.
60. Rumble J.R., Cooper M.E., Soulis T., Cox A., Wu L., Youssef S., Jasik M., Jerums G., Gilbert R.E. Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products. J. Clin. Invest. 1997, 99:1016-1027.
61. Schaper N.C., Nabuurs-Franssen M.H., Huijberts M.S. Peripheral vascular disease and type 2 diabetes mellitus. Diabetes Metab. Res. Rev. 2000, 16(Suppl. 1):S11-S15.
62. Silvestre J.S., Mallat Z., Tedgui A., Levy B.I. Post-ischaemic neovascularization and inflammation. Cardiovasc. Res. 2008, 78:242-249.
63. Tamarat R., Silvestre J.S., Huijberts M., Benessiano J., Ebrahimian T.G., Duriez M., Wautier M.P., Wautier J.L., Levy B.I. Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:8555-8560.
64. Teixeira-Lemos E., Nunes S., Teixeira F., Reis F. Regular physical exercise training assists in preventing type 2 diabetes development: focus on its antioxidant and anti-inflammatory properties. Cardiovasc. Diabetol. 2011, 10:12.
65. Traupe T., Lang M., Goettsch W., Munter K., Morawietz H., Vetter W., Barton M. Obesity increases prostanoid-mediated vasoconstriction and vascular thromboxane receptor gene expression. J. Hypertens. 2002, 20:2239-2245.
66. Tulis D.A., Unthank J.L., Prewitt R.L. Flow-induced arterial remodeling in rat mesenteric vasculature. Am. J. Physiol. 1998, 274:H874-H882.
67. Turhan H., Yasar A.S., Erbay A.R., Yetkin E., Sasmaz H., Sabah I. Impaired coronary collateral vessel development in patients with metabolic syndrome. Coron. Artery Dis. 2005, 16:281-285.
68. Tuttle J.L., Hahn T.L., Sanders B.M., Witzmann F.A., Miller S.J., Dalsing M.C., Unthank J.L. Impaired collateral development in mature rats. Am. J. Physiol. Heart Circ. Physiol. 2002, 283:H146-H155.
69. Tuttle J.L., Sanders B.M., Burkhart H.M., Fath S.W., Kerr K.A., Watson W.C., Herring B.P., Dalsing M.C., Unthank J.L. Impaired collateral artery development in spontaneously hypertensive rats. Microcirculation 2002, 9:343-351.
70. Unthank J.L., Fath S.W., Burkhart H.M., Miller S.C., Dalsing M.C. Wall remodeling during luminal expansion of mesenteric arterial collaterals in the rat. Circ. Res. 1996, 79:1015-1023.
71. van Golde J.M., Ruiter M.S., Schaper N.C., Voo S., Waltenberger J., Backes W.H., Post M.J., Huijberts M.S. Impaired collateral recruitment and outward remodeling in experimental diabetes. Diabetes 2008, 57:2818-2823.
72. Yamamoto K., Ando J. New molecular mechanisms for cardiovascular disease: blood flow sensing mechanism in vascular endothelial cells. J. Pharmacol. Sci. 2011, 116:323-331.
73. Yan C., Huang A., Kaley G., Sun D. Chronic high blood flow potentiates shear stress-induced release of no in arteries of aged rats. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H3105-H3110.
74. Yeon D.S., Kim J.S., Ahn D.S., Kwon S.C., Kang B.S., Morgan K.G., Lee Y.H. Role of protein kinase c- or rhoa-induced ca(2+) sensitization in stretch-induced myogenic tone. Cardiovasc. Res. 2002, 53:431-438.
75. Zanchi A., Delacretaz E., Taleb V., Gaillard R., Jeanrenaud B., Brunner H.R., Waeber B. Endothelial function of the mesenteric arteriole and mechanical behaviour of the carotid artery in rats with insulin resistance and hypercholesterolaemia. J. Hypertens. 1995, 13:1463-1470.
76. Zhou X., Bohlen H.G., Miller S.J., Unthank J.L. Nad(p)h oxidase-derived peroxide mediates elevated basal and impaired flow-induced no production in shr mesenteric arteries in vivo. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H1008-H1016.
77. Zhou X., Bohlen H.G., Unthank J.L., Miller S.J. Abnormal nitric oxide production in aged rat mesenteric arteries is mediated by nad(p)h oxidase-derived peroxide. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H2227-H2233.